Alli M. Nuotio-Antar's Profile
About Alli M. Nuotio-Antar
A trained biomedical researcher, Alli Antar, Ph.D. currently works at Baylor College of Medicine, where her projects complement her graduate studies on obesity, whole-body insulin resistance, and lipid metabolism. Dr. Antar’s previous publications have focused on metabolic syndrome and atherogenesis in obese, hyperlipidemic mice as well as on the developmental expression of 11beta-HSD1 in the murine thymus.
Alli Antar received her Ph.D. in 2007 from the Department of Molecular Physiology and Biophysics at Vanderbilt University. While a graduate student at Vanderbilt, Dr. Antar was nominated for and joined the scientific honor society Sigma Xi and received Lupus Foundation of America Student Stipend and the VUMC-NIH/CHHD Reproductive Biology Pre-doctoral Training Grant awards. As a post-doctoral fellow, Alli Antar was awarded NIH Training and AHA Postdoctoral Fellowship Grants. Dr. Antar is a member of the American Diabetes Association, the American Heart Association, the Obesity Society, the American Association for the Advancement of Science, the Endocrine Society, and the American Physiological Society. In addition to her research, Alli Antar enjoys supervising graduate and undergraduate students in the lab, as well as reviewing manuscripts for several journals in her field.
Affiliations
| 2007 | - | present | : | Baylor College of Medicine |
Recent Publications
- Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP)Biochemical and Biophysical Research Communications, 395(3):395-400, May 2010. [doi]
- Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice American Journal of Physiology Endocrinology and Metabolism, 293(6), December 2007. [doi]